{
    "2021-10-11": [
        [
            {
                "time": "",
                "original_text": "迈瑞医疗：公司专注于医疗器械领域，在中医药领域无相关研发投入",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "医疗器械",
                        "中医药",
                        "研发投入"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗：公司在韩国市场的收入占总收入的比例较低，占有率还有很大的提升空间",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "韩国市场",
                        "收入比例",
                        "提升空间"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "紫金矿业50亿进军锂业，宁德时代却成最大赢家！",
                "features": {
                    "keywords": [
                        "紫金矿业",
                        "锂业",
                        "宁德时代",
                        "投资"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "矿业",
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2021年10月投资策略：关注三季报增长与估值切换",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "三季报",
                        "估值切换"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：默沙东新冠药数据公布 腾盛博药递交FDA+EUA申请",
                "features": {
                    "keywords": [
                        "医药行业",
                        "默沙东",
                        "新冠药",
                        "FDA",
                        "EUA"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国家财政部：137种医疗器械100%采购国产 前BMS全球高管任恒瑞副总裁【最新闻1011】",
                "features": {
                    "keywords": [
                        "财政部",
                        "医疗器械",
                        "国产化",
                        "恒瑞医药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股午盘综述：煤炭、军工、银行、保险造好，中国神华、招商银行大涨",
                "features": {
                    "keywords": [
                        "A股",
                        "煤炭",
                        "军工",
                        "银行",
                        "保险"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "煤炭",
                        "军工",
                        "银行",
                        "保险"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创业板指跌超1%，迈瑞医疗均跌近4%",
                "features": {
                    "keywords": [
                        "创业板指",
                        "迈瑞医疗",
                        "下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "A股10月解禁市值超4800亿元 迈瑞医疗规模居首 解禁",
                "features": {
                    "keywords": [
                        "A股",
                        "解禁",
                        "迈瑞医疗"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "前三季度机构调研热情高涨，迈瑞医疗被“翻牌”最多",
                "features": {
                    "keywords": [
                        "机构调研",
                        "迈瑞医疗",
                        "热情高涨"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：本周医药板块上涨0.27 建议关注双限政策及新冠药物板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "双限政策",
                        "新冠药物",
                        "上涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}